Company intelligence / Profile preview

ALL DIAG

Geispolsheim, Grand Est, France

Ownership: Private
Employees: ~30
Development stage: Other

Overview

All Diag is a French medical diagnostics company that specializes in the development and distribution of in vitro diagnostic (IVD) solutions for professional and consumer use. The company is particularly recognized for its "Exacto" brand, which encompasses a variety of rapid diagnostic tests, and its pioneering "Autotest Gluten" for the screening of celiac disease. Following its acquisition by Biosynex in 2016, All Diag has integrated its operations to provide a comprehensive portfolio of biochemistry, hematology, and point-of-care testing products. The company serves a global market, focusing on high-quality, user-friendly diagnostic tools that facilitate rapid clinical decision-making.

Therapeutic areas: Infectious DiseasesWomen's HealthGastroenterology
Modalities: Device
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on ALL DIAG.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ALL DIAG.

Explore the full profile